Current Management and Unmet Needs in Alopecia Areata: Viewpoint From a Malaysian Perspective - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Management Strategies and Existing Gaps in Alopecia Areata: Insights from Malaysia

  • By

  • Azura Mohd Affandi

  • Adawiyah Jamil

  • Noor Zalmy Azizan

  • Felix Boon-Bin Yap

  • Kin Fon Leong

  • Agnes Yoke Hui Heng

  • Siti Nuraihan

  • Wooi Chiang Tan

  • Latha Selvarajah

  • Teeba Raja

  • Evelyn Wen Yee Yap

  • Peter Wee Beng Ch'ng

  • Tze Yuen Teoh

  • Mei Ying Tey

  • September 21, 2026

Share

Management Strategies and Existing Gaps in Alopecia Areata: Insights from Malaysia

Background

Alopecia areata is a chronic autoimmune disorder that leads to nonscarring hair loss, affecting approximately 1 in 1000 individuals. Understanding the management strategies and gaps in care is crucial for improving patient outcomes.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

  • Alopecia areata is characterized by patchy hair loss and can occur at any age.
  • Comorbidities associated with AA include vitiligo, lupus, and psychiatric disorders.
  • Initial management often involves topical corticosteroids, with referrals to dermatology for uncertain diagnoses or severe cases.
  • Malaysia lacks a specific national clinical practice guideline for alopecia areata.

Clinical Implications

Healthcare providers should be aware of the psychological effects of alopecia areata and consider mental health referrals as part of the management plan. Additionally, recognizing the need for specialist care in complex cases is essential for optimal patient management.

Conclusion

The management of alopecia areata in Malaysia reveals significant gaps in care and highlights the importance of addressing both physical and psychological aspects of the disorder.

Related Resources & Content

  1. Jolkovsky EL, Goldberg DJ, Dermatol Rev, 2024 -- Alopecia areata treatment: past, present, and future
  2. Lepe K, Syed HA, Zito PM, StatPearls, 2025 -- Alopecia areata
  3. Sibbald C, J Cutan Med Surg, 2023 -- Alopecia areata: an updated review for 2023
  4. Lee S et al., J Am Acad Dermatol, 2019 -- Comorbidities in alopecia areata: a systematic review and meta-analysis
  5. You HR, Kim SJ, Ann Dermatol, 2017 -- Factors associated with severity of alopecia areata
  6. Dermatology and Therapy — Insights from Dermatologists on the Severity, Impact, and Healthcare Resource Use for Alopecia Areata in Adults in the United Arab Emirates
  7. JMIR Dermatology — Exploring Social Media Conversations on Alopecia Areata Across Five Gulf Cooperation Council Nations: A Listening Study
  8. Frontiers in Medicine — Management of Concurrent Alopecia Areata and Systemic Lupus Erythematosus Using Ivarmacitinib: A Case Study and Review of Existing Literature
  9. MDSpire News — Skin Disease Type May Drive Medication Adherence
  10. British Association of Dermatologists living guideline for managing people with alopecia areata 2024
  11. Two Phase 3 Trials of Baricitinib for Alopecia Areata
  12. Frontiers | Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis

Original Source(s)

Related Content